Americans unhappy with drug prices

Caitlin Wilson | | Health Exec | Precision Medicine

Americans aren’t happy with a lot of things these days, including the prices of their prescription drugs, Fortune reported.

A survey from the Henry J. Kaiser Family Foundation in September found that 77 percent think prescription drug costs are too high. That figure is up from 72 percent who had the same complaint last year.

Forbes pointed out that the increased dissatisfaction could be abetted by the recent controversy surrounding drug-maker Mylan’s EpiPen price hike to up to $600 over the last 10 years.

On top of the general dissatisfaction with drug prices, 26 percent of those surveyed said they had a hard time paying for their own prescriptions and supported ideas for ways of reducing those costs.

Check out Fortune to see which ideas the Americans surveyed were most in favor of to reduce drug costs. 

More and More Americans Think Prescription Drug Costs Are 'Unreasonable'

Caitlin Wilson,

Senior Writer

As a Senior Writer at TriMed Media Group, Caitlin covers breaking news across several facets of the healthcare industry for all of TriMed's brands.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Design by Adaptive Theme
Trimed Popup
Trimed Popup